Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Vomiting can happen with retatrutide, especially at higher doses or after dose increases
Generally, youre looking at anywhere from 6 to 12 months on the short end and 2 to 3 years on average, depending on the factors listed above
Sterile, nonpyrogenic preparation for laboratory use
The three receptors targeted by retatrutide are: GLP-1R (Glucagon-like peptide-1 receptor) a well-established target already exploited by approved medicines such as semaglutide and liraglutide GIPR (Glucose-dependent insulinotropic polypeptide receptor) also targeted by tirzepatide in combination with GLP-1R GCGR (Glucagon receptor) an additional target that distinguishes retatrutide from currently approved dual agonists This triple mechanism of action places retatrutide in a distinct pharmacological class
Widely available as a pre-blended vial, simplifying dosing versus sourcing and mixing two peptides separately
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
